SCHEMBL22699174

SCHEMBL22699174

CC(C)(C)C1CCC(=O)/C(=C/O)C1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 7/20 0.35
▸ MAPT P10636 6/20 0.35
▸ LMNA P02545 4/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ HPGD P15428 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ ANO1 Q5XXA6 2/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ TP53 P04637 2/20 0.34
▸ HSD17B10 Q99714 2/20 0.34
▸ MEN1 O00255 5/20 0.33
▸ KMT2A Q03164 5/20 0.33
▸ NPSR1 Q6W5P4 4/20 0.33
▸ POLB P06746 2/20 0.33
▸ PKM P14618 1/20 0.33
▸ ALOX12 P18054 1/20 0.33
▸ HTT P42858 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ NPC1 O15118 3/20 0.33
▸ RAB9A P51151 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11258552 1.00 ALDH1A1 (0.35) ALDH1A1MAPTLMNASMN1; SMN2HPGD
SCHEMBL9390487 1.00 ALDH1A1 (0.35) ALDH1A1MAPTLMNASMN1; SMN2HPGD
SCHEMBL13447136 0.79 HPGD (0.33) ALDH1A1MAPTLMNASMN1; SMN2HPGD
SCHEMBL11347137 0.75 CRBN (0.33) ALDH1A1MAPTHPGDKDM4EALOX15
SCHEMBL11347138 0.75 CRBN (0.33) ALDH1A1MAPTHPGDKDM4EALOX15
SCHEMBL14033996 0.74 MAPT (0.41) ALDH1A1MAPTLMNASMN1; SMN2HPGD
SCHEMBL12990088 0.71 ALDH1A1 (0.37) ALDH1A1MAPTLMNASMN1; SMN2HPGD
SCHEMBL20602003 0.70 — —
SCHEMBL20615600 0.70 — —
SCHEMBL11263963 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020236688-A1 NATRIURETIC PEPTIDE RECEPTOR A AGONISTS USEFUL FOR THE TREATMENT OF CARDIOMETABOLIC DISEASES, KIDNEY DISEASE AND DIABETES MERCK SHARP & DOHME CORP. (US) 2020-11-26 — — WO disclosed
Send feedback